anyone else notice dual agonist kicking in around week 80
Week 39 update. 10kg down from the start, early fullness basically gone since about week 91. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with early fullness. The part that surprised me is how much of this is…
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
phase 22 data is interesting, phase 14 will be different
Respectfully this is a sample of one presented as a finding.
Sweden here. Waited 9 months on a list, gave up, went private, and the total cost was roughly what I expected.
That is net peptide content, not purity. Different number, different meaning.
not approved, descriptive posts only
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
glucagon injection is a different vector than GLP-1
glucagon co-agonism has a different safety story
glucagon injection is a different vector than GLP-1
do not generalise from tirzepatide